Olanzapine compared to quetiapine in adolescents with a first psychotic episode

@article{Arango2009OlanzapineCT,
  title={Olanzapine compared to quetiapine in adolescents with a first psychotic episode},
  author={PhD Celso Arango and Olalla Robles and PhD Mara Parellada and David Fraguas and Ana Ruiz-Sancho and Oscar D Medina and Arantzazu Zabala and Igor Bomb{\'i}n and PhD Dolores Moreno},
  journal={European Child & Adolescent Psychiatry},
  year={2009},
  volume={18},
  pages={418-428}
}
To compare the efficacy, safety, and tolerability of olanzapine and quetiapine in adolescents with first episode psychosis. Fifty adolescents (age 16 ± 1.25) with a first episode of psychosis were randomized to quetiapine or olanzapine in a 6-month open label study. Efficacy and side effect scales, as well as vital signs and laboratory data were recorded at baseline, 7, 15, 30, 90, and 180 days (end of study). Out of the total sample included in the study, 32 patients completed the trial… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.

Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent • 2010
View 6 Excerpts
Highly Influenced

Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology • 2011
View 5 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Similar Papers

Loading similar papers…